Company: Brainstorm Cell Therapeutics
Job title: Head, R&D
Dr. Revital Aricha joined BrainStorm in March 2015 and serves as Vice President of Research and Development. Prior to joining BrainStorm, she served as a scientist at the Department of Immunology of the Weizmann Institute of Science since 2006, where she specialized in autoimmunity related to neuromuscular pathology and regulatory processes.
Dr. Aricha completed her postdoctoral fellowship at the Weizmann Institute of Science. She received her PhD in Neurobiology from the Bar-Ilan University in Israel.
MSC-NTF Exosomes as a Potential Treatment for Covid-19 ARDS & Related Disorders 1:00 pm
Review of MSC and MSC-NTF exosome in vitro characteristics Potential application MSC-NTF exosomes in COVID-ARDS and other related disorders MSC-NTF vs. MSC exosomes preclinical data in ARDS modelRead more
day: Day Two